Log in
NASDAQ:PCVX

Legend Biotech Stock Forecast, Price & News

$51.50
-0.31 (-0.60 %)
(As of 09/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$51.40
Now: $51.50
$53.40
50-Day Range
$35.94
MA: $46.14
$55.40
52-Week Range
$17.80
Now: $51.50
$58.47
Volume170,368 shs
Average Volume222,769 shs
Market Capitalization$2.62 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Vaxcyte, Inc. a biopharmaceutical company, develops vaccines for infectious diseases. It offers conjugate, pneumococcal conjugate, and complex antigen-based vaccines. The company has a license to Sutro Biopharma's Xpress CF platforms for cell free protein synthesis and site-specific conjugation. Vaxcyte, Inc. was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May, 2020. The company was incorporated in 2013 and is based in Foster City, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.71 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PCVX
CUSIPN/A
CIKN/A
Phone650-837-0111

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees43
Market Cap$2.62 billion
Next Earnings Date11/11/2020 (Estimated)
OptionableNot Optionable
$51.50
-0.31 (-0.60 %)
(As of 09/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PCVX News and Ratings via Email

Sign-up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Legend Biotech (NASDAQ:PCVX) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Legend Biotech?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Legend Biotech in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Legend Biotech
.

When is Legend Biotech's next earnings date?

Legend Biotech is scheduled to release its next quarterly earnings announcement on Wednesday, November 11th 2020.
View our earnings forecast for Legend Biotech
.

What price target have analysts set for PCVX?

5 analysts have issued 1-year price objectives for Legend Biotech's stock. Their forecasts range from $37.00 to $55.00. On average, they expect Legend Biotech's share price to reach $45.25 in the next year. This suggests that the stock has a possible downside of 12.1%.
View analysts' price targets for Legend Biotech
.

Who are some of Legend Biotech's key competitors?

What other stocks do shareholders of Legend Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Legend Biotech investors own include NVIDIA (NVDA), Twilio (TWLO), Boeing (BA), Overstock.com (OSTK), Pure Storage (PSTG), QUALCOMM (QCOM), Riot Blockchain (RIOT), American Tower (AMT), Avid Technology (AVID) and CalAmp (CAMP).

Who are Legend Biotech's key executives?

Legend Biotech's management team includes the following people:
  • Mr. Grant E. Pickering, Co-Founder, CEO, Pres & Director (Age 52)
  • Dr. Ashish Khanna, Co-Founder and Chief Bus. Officer
  • Dr. Jeff Fairman, Co-Founder & VP of Research (Age 56)
  • Mr. Andrew L. Guggenhime M.B.A., CFO & Chief Bus. Officer (Age 52)
  • Mr. James Wassil M.B.A., M.S., Chief Operating Officer (Age 50)

When did Legend Biotech IPO?

(PCVX) raised $210 million in an initial public offering (IPO) on Friday, June 12th 2020. The company issued 14,000,000 shares at $14.00-$16.00 per share. BofA Securities, Jefferies and Evercore ISI served as the underwriters for the IPO and Cantor and Needham & Company were co-managers.

What is Legend Biotech's stock symbol?

Legend Biotech trades on the NASDAQ under the ticker symbol "PCVX."

When does Legend Biotech's lock-up period expire?

Legend Biotech's lock-up period expires on Wednesday, December 9th. Legend Biotech had issued 15,625,000 shares in its initial public offering on June 12th. The total size of the offering was $250,000,000 based on an initial share price of $16.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

How do I buy shares of Legend Biotech?

Shares of PCVX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Legend Biotech's stock price today?

One share of PCVX stock can currently be purchased for approximately $51.50.

How big of a company is Legend Biotech?

Legend Biotech has a market capitalization of $2.62 billion. Legend Biotech employs 43 workers across the globe.

What is Legend Biotech's official website?

The official website for Legend Biotech is www.vaxcyte.com.

How can I contact Legend Biotech?

Legend Biotech's mailing address is 353 HATCH DRIVE, FOSTER CITY CA, 94404. The company can be reached via phone at 650-837-0111.

This page was last updated on 9/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.